COVID-19 and Sirolimus Treatment in a Kidney Transplant Recipient.
Exp Clin Transplant
; 19(9): 977-980, 2021 09.
مقالة
ي الانجليزية
| MEDLINE | ID: covidwho-1404031
ABSTRACT
One year after COVID-19 was declared a pandemic, the management of the disease in kidney transplant patients remains uncertain. The interruption of immunosuppressive therapy is frequently suggested in kidney transplant recipients with COVID-19; however, such an interruption potentially increases the risk of allograft rejection and hyperimmune response. We here report the successful treatment of COVID-19 pneumonia in a kidney transplant recipient who received a sirolimus-based regimen. The course of COVID-19 management was favorable for maintaining sirolimus treatment. Nevertheless, the patient showed signs of extreme overexposure to sirolimus because of drug interaction with antiviral treatment. This case illustrates the advantages and related adverse events of sirolimus-based immunosuppression in the management of COVID-19 in kidney transplant recipients.
النص الكامل:
متاح
مجموعة:
قواعد البيانات الدولية
قاعدة البيانات:
MEDLINE
الموضوع الرئيسي:
Kidney Transplantation
/
Sirolimus
/
COVID-19
نوع الدراسة:
تقرير الحالة
/
دراسة النذير
المحددات:
البشر
/
ذكر
/
منتصف العمر
اللغة:
الانجليزية
مجلة:
Exp Clin Transplant
موضوع المجلة:
نقل/زرع الأعضاء
السنة:
2021
نوع:
مقالة
المراجع ذات الصلة
MEDLINE
...
LILACS
LIS